TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
JBIO

Jade Biosciences, Inc.

Healthcare · Biotechnology

14.70$ +0.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JBIO
Line item 2020 2021 2022 2023 2024 2025
– +3,619.3% -22.8% -5.8% -37.0% +335.4%
– +3,628.3% -24.6% -5.5% -35.5% +319.6%
– +1,085.2% -58.7% +4.9% +43.7% +162.0%
– +3,560.1% -22.8% -5.2% -35.8% +327.6%
– +66.0% +190.6% +109.9% -78.3% +342.9%
– +43.7% +205.2% +126.6% -78.3% +332.1%
– – +100.5% +9.1% -0.7% –
– +95.5% +113.2% -7.0% -90.7% +860.3%
– – – – – –
– +5,762.6% -26.5% -13.6% -30.2% +335.0%
– – – – – –
– +0.0% +0.3% +7.6% +8.5% +3,740.1%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?